1-氯乙基乙基碳酸酯 | 50893-36-2

• 物质功能分类: 化学试剂 - 有机试剂 - 酯类
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机碳酸及其衍生物
• 中文名称: 1-氯乙基乙基碳酸酯
• 中文别名: 1-氯乙基碳酸乙酯；碳酸-1-氯乙基乙酯
• 英文名称: 1-Chloroethyl ethyl carbonate
• 英文别名: carbonic acid ethyl ester-(1-chloro-ethyl ester)
• CAS: 50893-36-2
• 化学式: C₅H₉ClO₃
• mdl: MFCD00040523
• 分子量: 152.578
• InChiKey: YVRGKFXJZCTTRB-UHFFFAOYSA-N

物化性质

• 熔点：
  159-161°C
• 沸点：
  159-161 °C(lit.)
• 密度：
  1.136 g/mL at 20 °C(lit.)
• 闪点：
  65°C
• 溶解度：
  溶于氯仿
• 稳定性/保质期：

  如果按照规格使用和储存，不会发生分解，也没有已知的危险反应。

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  9
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S28
• 危险类别码：
  R36/37/38
• WGK Germany：
  3
• 海关编码：
  2920909090
• 危险性防范说明：
  P305+P351+P338
• 危险性描述：
  H227,H315,H319,H335
• 储存条件：
  请将贮藏器密封保存，并存放在阴凉、干燥处。同时，确保工作环境有良好的通风或排气设施。

SDS

1-Chloroethyl Ethyl Carbonate Revision number: 5
SAFETY DATA SHEET

---

Section 1. IDENTIFICATION
Product name: 1-Chloroethyl Ethyl Carbonate

Revision number: 5

---

Section 2. HAZARDS IDENTIFICATION
GHS classification
PHYSICAL HAZARDS
Category 4
Flammable liquids
HEALTH HAZARDS
Category 2
Skin corrosion/irritation
Serious eye damage/eye irritation Category 2A
Not classified
ENVIRONMENTAL HAZARDS
GHS label elements, including precautionary statements
Pictograms or hazard symbols
Signal word Warning
Hazard statements Combustible liquid
Causes skin irritation
Causes serious eye irritation
Precautionary statements:
Keep away from flames and hot surfaces.
[Prevention]
Wash hands thoroughly after handling.
Wear protective gloves and eye/face protection.
[Response] IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses,
if present and easy to do. Continue rinsing.
If eye irritation persists: Get medical advice/attention.
IF ON SKIN: Gently wash with plenty of soap and water.
If skin irritation occurs: Get medical advice/attention.
Take off contaminated clothing and wash before reuse.
[Storage] Store in a well-ventilated place. Keep cool.
[Disposal] Dispose of contents/container through a waste management company authorized by
the local government.

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substance/mixture: Substance
Components: 1-Chloroethyl Ethyl Carbonate
Percent: >98.0%(GC)
50893-36-2
CAS Number:
Synonyms: Carbonic Acid 1-Chloroethyl Ethyl Ester , 1-Chlorodiethyl Carbonate
1-Chloroethyl Ethyl Carbonate

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Chemical Formula: C5H9ClO3

---

Section 4. FIRST AID MEASURES
Inhalation: Remove victim to fresh air and keep at rest in a position comfortable for breathing.
Get medical advice/attention if you feel unwell.
Skin contact: Remove/Take off immediately all contaminated clothing. Gently wash with plenty of
soap and water. If skin irritation or rash occurs: Get medical advice/attention.
Eye contact: Rinse cautiously with water for several minutes. Remove contact lenses, if present
and easy to do. Continue rinsing. If eye irritation persists: Get medical
advice/attention.
Get medical advice/attention if you feel unwell. Rinse mouth.
Ingestion:
Protection of first-aiders: A rescuer should wear personal protective equipment, such as rubber gloves and air-
tight goggles.

---

Section 5. FIRE-FIGHTING MEASURES
Dry chemical, foam, water spray, carbon dioxide.
Suitable extinguishing
media:
Unsuitable extinguishing Solid streams of water
media:
Specific hazards arising Take care as it may decompose upon combustion or in high temperatures to
from the chemical: generate poisonous fume.
Precautions for firefighters: Fire-extinguishing work is done from the windward and the suitable fire-extinguishing
method according to the surrounding situation is used. Uninvolved persons should
evacuate to a safe place. In case of fire in the surroundings: Remove movable
containers if safe to do so.
Special protective When extinguishing fire, be sure to wear personal protective equipment.
equipment for firefighters:

---

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, Use personal protective equipment. Keep people away from and upwind of spill/leak.
protective equipment and Ensure adequate ventilation. Entry to non-involved personnel should be controlled
emergency procedures: around the leakage area by roping off, etc.
Environmental precautions: Prevent product from entering drains.
Methods and materials for Absorb spilled material in a suitable absorbent (e.g. rag, dry sand, earth, saw-dust).
containment and cleaning In case of large amount of spillage, contain a spill by bunding. Adhered or collected
up: material should be promptly disposed of, in accordance with appropriate laws and
regulations.
Prevention of secondary Remove all sources of ignition. Fire-extinguishing devices should be prepared in
case of a fire. Use spark-proof tools and explosion-proof equipment.
hazards:

---

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Technical measures: Handling is performed in a well ventilated place. Wear suitable protective equipment.
Prevent generation of vapour or mist. Keep away from flames and hot surfaces. Take
measures to prevent the build up of electrostatic charge. Use explosion-proof
equipment. Wash hands and face thoroughly after handling.
Use a closed system, ventilation.
Advice on safe handling: Avoid contact with skin, eyes and clothing.
Conditions for safe storage, including any
incompatibilities
Storage conditions: Keep container tightly closed. Store in a cool, dark and well-ventilated place.
Store under inert gas.
Protect from moisture.
Store away from incompatible materials such as oxidizing agents.
Moisture-sensitive
Comply with laws.
Packaging material:
1-Chloroethyl Ethyl Carbonate

---

Section 8. EXPOSURE CONTROLS / PERSONAL PROTECTION
Engineering controls: Install a closed system or local exhaust as possible so that workers should not be
exposed directly. Also install safety shower and eye bath.
Personal protective equipment
Respiratory protection: Vapor respirator. Follow local and national regulations.
Protective gloves.
Hand protection:
Eye protection: Safety glasses. A face-shield, if the situation requires.
Skin and body protection: Protective clothing. Protective boots, if the situation requires.

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Physical state (20°C): Liquid
Form: Clear
Colorless - Slightly pale yellow
Colour:
Odour: No data available
pH: No data available
Melting point/freezing point:No data available
Boiling point/range: 160°C
Flash point: 62°C
Flammability or explosive
limits:
Lower: No data available
Upper: No data available
Relative density: 1.14
Solubility(ies):
No data available
[Water]
[Other solvents] No data available

---

Section 10. STABILITY AND REACTIVITY
Chemical stability: Stable under proper conditions.
Possibility of hazardous No special reactivity has been reported.
reactions:
Open flame
Conditions to avoid:
Incompatible materials: Oxidizing agents
Hazardous decomposition Carbon monoxide, Carbon dioxide, Hydrogen chloride
products:

---

Section 11. TOXICOLOGICAL INFORMATION
Acute Toxicity: No data available
Skin corrosion/irritation: No data available
Serious eye No data available
damage/irritation:
Germ cell mutagenicity: No data available
Carcinogenicity:
No data available
IARC =
NTP = No data available
Reproductive toxicity: No data available

---

Section 12. ECOLOGICAL INFORMATION
Ecotoxicity:
Fish: No data available
Crustacea: No data available
Algae: No data available
Persistence / degradability: No data available
Bioaccumulative No data available
potential(BCF):
Mobility in soil
1-Chloroethyl Ethyl Carbonate

---

Section 12. ECOLOGICAL INFORMATION
Log Pow: No data available
Soil adsorption (Koc): No data available
Henry's Law No data available
constant(PaM3/mol):

---

Section 13. DISPOSAL CONSIDERATIONS
Recycle to process, if possible. Consult your local regional authorities. You may be able to burn in a chemical
incinerator equipped with an afterburner and scrubber system. Observe all federal, state and local regulations when
disposing of the substance.

---

Section 14. TRANSPORT INFORMATION
Hazards Class: Does not correspond to the classification standard of the United Nations
UN-No: Not listed

---

Section 15. REGULATORY INFORMATION
Safe management ordinance of dangerous chemical product (State Council announces on January 26, 2002
and revised on February 16,2011): Safe use and production, the storage of a dangerous chemical, transport,
loading and unloading were prescribed.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

用途：用于生产坎地沙坦酯、头孢替安酯等药物的中间体。

反应信息

• 作为反应物：
  描述：

  1-氯乙基乙基碳酸酯 在 18-冠醚-6 、 sodium iodide 作用下， 以 甲苯 为溶剂， 反应 2.0h， 生成 1-碘乙基乙基碳酸酯
  参考文献：
  名称：

  Synthesis and Characterization of Novel Analogues of Cefpodoxime Proxetil

  摘要：

  这项工作描述了四种头孢匹多克肟的新类似物的起源、鉴定、合成、表征和控制，它们分别是头孢匹多克肟的乙基、甲基、丙基和N-丙基类似物。

  DOI：

  10.14233/ajchem.2020.22666
• 作为产物：
  描述：

  1-氯乙基氯甲酸酯 在 吡啶 作用下， 以 乙醇 、 二氯甲烷 为溶剂， 生成 1-氯乙基乙基碳酸酯
  参考文献：
  名称：

  [(Alkoxycarbonyl)oxy]alkyl esters of methyldopa

  摘要：

  本发明揭示了甲基多巴的新型前药，其为甲基多巴的[(烷氧羰基)氧基]烷基酯。同时，本发明还揭示了含有这些化合物的药物组合物。在给温血动物施用时，这些前药会释放出甲基多巴以及无害的副产物。

  公开号：

  US04426391A1
• 作为试剂：
  描述：

  6-羟基异喹啉 在 sodium tetrahydroborate 、 1-氯乙基乙基碳酸酯 、 potassium carbonate 、 1-羟基苯并三唑 、 一水合肼 、 三乙胺 、 N,N'-二环己基碳二亚胺 、 sodium hydroxide 作用下， 以 四氢呋喃 、 甲醇 、 乙醇 、 二氯甲烷 、 乙二醇二乙醚 、 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 71.58h， 生成
  参考文献：
  名称：

  EP3747883

  摘要：

  公开号：

文献信息

• Alkyl 1-Chloroalkyl Carbonates: Reagents for the Synthesis of Carbamates and Protection of Amino Groups
  作者：Gérard Barcelo、Jean-Pierre Senet、Gérard Sennyey、Jean Bensoam、Albert Loffet

  DOI：10.1055/s-1986-31724

  日期：——

  The synthesis of 1-chloroalkyl carbonates and their reaction with various type of amines are described. This reaction is useful for the synthesis of carbamate pesticides and for the protection of various amino groups, including amino acids.

  描述了1-氯代烷基碳酸酯的合成及其与各种类型胺的反应。这一反应对于合成氨基甲酸酯类农药和保护包括氨基酸在内的各种氨基团具有重要作用。
• [EN] PRODRUGS OF D-ISOGLUTAMYL-[D/L]-TRYPTOPHAN<br/>[FR] PROMÉDICAMENTS DE D-ISOGLUTAMYL-[D/L]-TRYPTOPHANE
  申请人：APOTEX TECHNOLOGIES INC

  公开号：WO2012129671A1

  公开（公告）日：2012-10-04

  Provided are carboxylic ester derivatives of formula (I), methods of preparing them, and methods for using them. These compounds are prodrugs of D-isoglutamyl-[D/L]-tryptophan. The in vitro bioconversion of some of the prodrugs to the parent drug D-isoglutamyl-D-tryptophan (or thymodepressin) was tested in human hepatocytes and in human blood. In vivo pharmacokinetic studies following oral administration of some of the prodrugs to rats are also reported.

  提供了公式（I）的羧酸酯衍生物，其制备方法以及使用方法。这些化合物是D-异谷氨酰-[D/L]-色氨酸的前药。对一些前药在人类肝细胞和人类血液中转化为母药D-异谷氨酰-D-色氨酸（或胸腺抑制素）的体外生物转化进行了测试。还报告了将一些前药口服给大鼠后的体内药代动力学研究。
• [EN] COMPOUNDS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS<br/>[FR] COMPOSÉS ET PROCÉDÉS POUR LE TRAITEMENT DE TROUBLES OCULAIRES
  申请人：AZURA OPHTHALMICS LTD

  公开号：WO2020212755A1

  公开（公告）日：2020-10-22

  Described herein are compositions and methods for the treatment of ocular surface disorders including meibomian gland dysfunction, blepharitis, dry eye disease and other inflammatory and/or infectious disease of the anterior surface of the eye. Said compositions and methods comprise keratolytic conjugates which demonstrate keratolytic activity, and anti- inflammatory or other desirable activities. Topical administration of said compositions to the eyelid margin or surrounding areas provides therapeutic benefit to patients suffering from ocular surface disorders.

  本文描述了用于治疗眼表面疾病的组合物和方法，包括睑板腺功能障碍、睑缘炎、干眼症和其他眼前表面的炎症和/或感染性疾病。所述组合物和方法包括表现出角质溶解活性的角质溶解共轭物，以及抗炎或其他理想活性。将所述组合物局部施用于眼睑边缘或周围区域可为患有眼表面疾病的患者提供治疗益处。
• CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF
  申请人：Millennium Pharmaceuticals, Inc.

  公开号：US20160031908A1

  公开（公告）日：2016-02-04

  Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: or physiologically acceptable salt thereof.

  揭示了新颖的化合物以及治疗与异常白细胞召集和/或激活相关的疾病的方法。该方法包括向需要的受试者施用代表的化合物的有效量： 或其生理上可接受的盐。
• Chemokine receptor anagonists and methods of use therefor
  申请人：Millennium Pharmaceuticals, Inc.

  公开号：US20020169155A1

  公开（公告）日：2002-11-14

  Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: 1 or physiologically acceptable salt thereof.

  揭示了新颖的化合物以及一种治疗与异常白细胞召集和/或激活相关疾病的方法。该方法包括向需要的受试者施用化合物1或其生理上可接受的盐的有效量。

表征谱图